DE- MIGRAINE
Natural health product licensed in Canada
- Other names
- BETA -MIGRAINE, MIGRA - EZE, MIGRAINE - RELIEF, MIGRAINE - X, MIGRAINE-REX, MIGRAREF
- Licence holder
- 2640412 Ontario Inc.
- NPN or DIN-HM
- 80111322
- Status
- Active licence
- Licence date
- 13 July 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 mg | 50 mg | Not calculated |
| Scutellaria lateriflora L. (Lamiaceae) Source : Scutellaria lateriflora - Sommité (herbe) Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 mg | 100 mg | Not calculated |
| Valeriana officinalis Source : Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 mg Potency : 0.5 % Valerenic acid | 100 mg | Not calculated |
| Rosmarinus officinalis L. (Lamiaceae) Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 3,000 mg | 100 mg | Not calculated |
| Tanacetum parthenium (L.) Sch. Bip. (Asteraceae/Compositae) Extract : Matériel brut sec Extraction ratio : 1:1 Dry plant equivalent : 100 mg Potency : 1 % Parthenolide | 100 mg | Not calculated |
| Turnera diffusa Source : Feuille Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 1,500 mg | 100 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hydroxypropyl méthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 par jour |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Traditionally) used in Herbal Medicine to help ease (gastric) headaches and relieve flatulent indigestion (carminative). Feverfew is used in Herbal Medicine to) help(s) reduce the severity and/or frequency of migraine headaches and associated symptoms such as nausea and vomiting, when taken as a prophylactic. Skullcap is traditionally used in Herbal Medicine to help relieve restlessness and/or nervousness (calmative). Rosemary is (Traditionally) used in Herbal Medicine to help ease (gastric) headaches and relieve flatulent indigestion (carminative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80111322
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.